MMS
MAXIMUS, INC.
Company overview
- Market capitalization
- $2.73B
- Employees
- 37,200
- Latest publication
- 2026-09-29
About MAXIMUS, INC.
Maximus, Inc. operates as a provider of government services worldwide. The company operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Federal Services segment offers business process services, eligibility and enrollment, outreach, and other services for federal health and human services programs; clinical services; and technology solutions, such as application development and modernization services, enterprise business solutions, advanced analytics and emerging technologies, cybersecurity services, data management, and infrastructure and engineering solutions. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; subsidized telephone services; and person-centered independent assessment services. This segment also provides employment services, such as eligibility support, case management, job-readiness preparation, job search and employer outreach, job retention and career advancement, and educational and training services; technology solutions; and system implementation project management services. The Outside the U.S. segment offers BPS and technology solutions for international governments, including health and disability assessments, program administration for employment services, wellbeing solutions and other job seeker-related services, digitally-enabled customer services, and technologies for modernization. Maximus, Inc. was founded in 1975 and is headquartered in McLean, Virginia.
Financial statements
Income Quarterly
| Metric | Q3 20262026-06-30 · USD | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,278,971,000USD | 1,305,967,000USD | 1,345,046,000USD | 1,318,415,000USD | 1,348,400,000USD | 1,361,786,000USD | 1,402,675,000USD | 1,315,870,000USD |
| Cost Of Revenue | 930,168,000USD | 984,001,000USD | 1,046,675,999USD | 1,007,869,000USD | 1,011,897,000USD | 1,045,961,000USD | 1,124,153,000USD | 1,037,213,000USD |
| Gross Profit | 348,803,000USD | 321,966,000USD | 298,370,000USD | 310,546,000USD | 336,503,000USD | 315,825,000USD | 278,522,000USD | 278,657,000USD |
| Selling General Administrative | 167,188,000USD | 173,479,000USD | 152,160,000USD | 187,684,000USD | 170,831,000USD | 162,857,000USD | 191,735,000USD | 166,901,000USD |
| Other Operating Expenses | 20,187,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 187,375,000USD | 173,479,000USD | 161,137,000USD | 186,996,000USD | 170,762,000USD | 162,860,000USD | 153,273,000USD | 165,990,000USD |
| Operating Income | 161,428,000USD | 148,487,000USD | 137,233,000USD | 123,550,000USD | 165,741,000USD | 152,965,000USD | 125,249,000USD | 112,667,000USD |
| Total Other Income Expense Net | -23,270,000USD | -21,953,000USD | -10,966,000USD | -23,083,000USD | -22,774,000USD | -20,503,000USD | -56,296,000USD | -19,998,000USD |
| Interest Expense | 23,878,000USD | 23,797,000USD | 19,130,000USD | 22,432,000USD | 22,657,000USD | 21,469,000USD | 17,522,000USD | 20,012,000USD |
| Income Before Tax | 138,158,000USD | 126,534,000USD | 126,267,000USD | 100,467,000USD | 142,967,000USD | 132,462,000USD | 68,953,000USD | 92,669,000USD |
| Income Tax Expense | 34,565,000USD | 28,471,000USD | 32,324,000USD | 25,179,000USD | 36,986,000USD | 35,893,000USD | 27,757,000USD | 20,165,000USD |
| Net Income | 103,593,000USD | 98,063,000USD | 93,943,000USD | 75,288,000USD | 105,981,000USD | 96,569,000USD | 41,196,000USD | 72,504,000USD |
| Net Interest Income | — | -22,111,000USD | -20,816,000USD | -22,432,000USD | -22,657,000USD | -21,469,000USD | -17,522,000USD | -20,012,000USD |
| Tax Provision | — | 28,471,000USD | 32,324,000USD | 25,179,000USD | 36,986,000USD | 35,893,000USD | 27,757,000USD | 20,165,000USD |
| Net Income From Continuing Ops | — | 98,063,000USD | 93,943,000USD | 75,288,000USD | 105,981,000USD | 96,569,000USD | 41,196,000USD | 72,504,000USD |
| Ebit | — | 150,331,000USD | 145,397,000USD | 122,899,000USD | 165,624,001USD | 153,931,000USD | 86,475,000USD | 112,681,001USD |
| Ebitda | — | 182,956,999USD | 178,586,000USD | 160,072,000USD | 198,241,000USD | 186,367,000USD | 117,965,000USD | 145,530,000USD |
| Depreciation And Amortization | — | 32,625,999USD | 33,189,000USD | 37,173,000USD | 32,616,999USD | 32,436,000USD | 31,490,000USD | 32,848,999USD |
| Reconciled Depreciation | — | 32,626,000USD | 33,189,000USD | 37,173,000USD | 32,617,000USD | 32,436,000USD | 31,490,000USD | 32,849,000USD |
| Unclassified Operating Expenses | — | — | 8,977,000USD | — | — | — | -38,462,000USD | — |
| Interest Income | — | — | 20,816,000USD | 22,432,000USD | 22,657,000USD | 21,469,000USD | 17,522,000USD | 20,012,000USD |
| Net Income Applicable To Common Shares | — | — | 93,943,000USD | 75,288,000USD | 105,981,000USD | 96,569,000USD | 41,196,000USD | 72,504,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 5,431,276,000USD | 5,306,197,000USD | 4,904,728,000USD | 4,631,018,000USD | 4,254,485,000USD | 3,461,537,000USD | 2,886,815,000USD | 2,392,236,000USD |
| Cost Of Revenue | 4,189,880,000USD | 4,146,115,000USD | 3,970,711,000USD | 3,781,673,000USD | 3,351,867,000USD | 2,786,169,000USD | 2,293,889,000USD | 1,808,159,000USD |
| Gross Profit | 1,249,883,000USD | 1,160,082,000USD | 934,017,000USD | 849,345,000USD | 902,618,000USD | 675,368,000USD | 592,926,000USD | 584,077,000USD |
| Selling General Administrative | 713,107,000USD | 671,583,000USD | 639,223,000USD | 534,493,000USD | 494,088,000USD | 387,090,000USD | 321,023,000USD | 285,241,000USD |
| Unclassified Operating Expenses | -39,976,000USD | — | — | — | -10,820,000USD | — | -47,904,000USD | — |
| Total Operating Expenses | 673,131,000USD | 668,365,000USD | 638,648,000USD | 537,561,000USD | 483,268,000USD | 384,187,000USD | 273,119,000USD | 284,294,000USD |
| Operating Income | 576,752,000USD | 491,717,000USD | 295,369,000USD | 311,784,000USD | 419,350,000USD | 291,181,000USD | 319,807,000USD | 299,783,000USD |
| Interest Income | 84,080,000USD | 82,440,000USD | 84,138,000USD | 45,965,000USD | 14,744,000USD | 2,059,000USD | 2,957,000USD | 3,726,000USD |
| Interest Expense | 84,080,000USD | 82,440,000USD | 84,138,000USD | 45,965,000USD | 14,744,000USD | 2,059,000USD | 2,957,000USD | 1,000,000USD |
| Net Interest Income | -84,080,000USD | -82,440,000USD | -84,138,000USD | -45,965,000USD | -14,744,000USD | -2,059,000USD | -2,957,000USD | -1,000,000USD |
| Income Before Tax | 444,849,000USD | 406,509,000USD | 210,293,000USD | 277,098,000USD | 383,681,000USD | 287,062,000USD | 317,320,000USD | 299,209,000USD |
| Income Tax Expense | 125,815,000USD | 99,595,000USD | 48,501,000USD | 73,270,000USD | 92,481,000USD | 72,553,000USD | 76,825,000USD | 78,393,000USD |
| Tax Provision | 125,815,000USD | 99,595,000USD | 48,501,000USD | 73,270,000USD | 92,481,000USD | 72,553,000USD | 77,306,000USD | 78,393,000USD |
| Net Income | 319,034,000USD | 306,914,000USD | 161,792,000USD | 203,828,000USD | 291,200,000USD | 214,509,000USD | 240,824,000USD | 220,751,000USD |
| Net Income From Continuing Ops | 319,034,000USD | 306,914,000USD | 161,792,000USD | 203,828,000USD | 291,200,000USD | 214,509,000USD | 240,495,000USD | 220,816,000USD |
| Ebit | 528,929,000USD | 488,949,000USD | 294,431,000USD | 323,063,000USD | 398,425,000USD | 289,121,000USD | 320,277,000USD | 300,209,000USD |
| Ebitda | 674,745,000USD | 624,276,000USD | 456,447,000USD | 464,758,000USD | 502,743,000USD | 396,082,000USD | 405,735,000USD | 362,401,000USD |
| Depreciation And Amortization | 145,816,000USD | 135,327,000USD | 162,016,000USD | 141,695,000USD | 104,318,000USD | 106,961,000USD | 85,458,000USD | 62,192,000USD |
| Reconciled Depreciation | 133,716,000USD | 125,527,000USD | 149,316,000USD | 132,795,000USD | 90,718,000USD | 100,161,000USD | 85,458,000USD | 62,192,000USD |
| Total Other Income Expense Net | -131,903,000USD | -85,208,000USD | -85,076,000USD | -34,686,000USD | -35,669,000USD | -4,119,000USD | -2,487,000USD | -574,000USD |
| Net Income Applicable To Common Shares | 319,034,000USD | 306,914,000USD | 161,792,000USD | 203,828,000USD | 291,200,000USD | 214,509,000USD | 240,824,000USD | 220,751,000USD |
| Non Operating Income Net Other | — | — | — | -2,835,000USD | -10,105,000USD | 843,000USD | — | 4,726,000USD |
| Minority Interest | — | — | — | — | 0USD | 48,000USD | 409,000USD | 65,000USD |
| Research Development | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q3 20262026-06-30 · USD | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 4,366,779,000USD | 4,239,174,000USD | 4,208,300,000USD | 4,069,639,000USD | 4,462,293,000USD | 4,199,772,000USD | 4,058,760,000USD | 4,131,508,000USD |
| Cash And Equivalents | 56,953,000USD | — | 137,594,000USD | 222,351,000USD | 59,777,000USD | 108,059,000USD | 72,653,000USD | 183,123,000USD |
| Total Current Assets | 1,641,363,000USD | 1,508,848,000USD | 1,423,208,000USD | 1,252,924,000USD | 1,605,031,000USD | 1,328,267,000USD | 1,165,378,000USD | 1,200,544,000USD |
| Other Current Assets | 171,377,000USD | 84,399,000USD | 137,874,000USD | 90,466,000USD | 71,644,000USD | 71,434,000USD | 78,474,000USD | 79,985,000USD |
| Other Non Current Assets | 13,553,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 2,626,228,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 678,069,000USD | 681,687,000USD | 608,046,000USD | 765,163,000USD | 706,151,000USD | 721,237,000USD | 678,925,000USD | 807,529,000USD |
| Other Current Liabilities | 121,142,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 24,002,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 1,740,551,000USD | 1,696,961,000USD | 1,719,812,000USD | 1,674,035,000USD | 1,773,036,000USD | 1,667,474,000USD | 1,646,849,000USD | 1,842,815,000USD |
| Total Equity Including Noncontrolling Interest | 1,740,551,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 71,599,000USD | 63,930,000USD | 58,305,000USD | 52,680,000USD | 48,263,000USD | 47,055,000USD | 34,945,000USD | 40,139,000USD |
| Long Term Debt | 1,565,336,000USD | 1,471,816,000USD | 1,509,205,000USD | 1,281,593,000USD | 1,608,982,000USD | 1,445,746,000USD | 1,353,217,000USD | 1,091,954,000USD |
| Deferred Revenue | 36,626,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 35,863,000USD | — | — | — | — | — | — | — |
| Net Receivables | 1,382,014,000USD | 1,179,752,000USD | 1,147,740,000USD | 901,999,000USD | 1,428,011,000USD | 1,100,895,000USD | 964,034,000USD | 884,796,000USD |
| Property Plant Equipment Net | 116,787,000USD | 111,275,000USD | 159,316,000USD | 131,485,999USD | 149,973,000USD | 153,185,000USD | 156,654,000USD | 172,571,000USD |
| Goodwill | 1,780,543,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 263,220,000USD | 281,984,000USD | 263,281,000USD | 296,888,000USD | 281,994,000USD | 306,445,000USD | 286,359,000USD | 303,321,000USD |
| Short Term Debt | 38,280,000USD | 99,330,000USD | 95,789,000USD | 91,285,000USD | 88,145,000USD | 85,843,000USD | 72,958,000USD | 87,795,000USD |
| Retained Earnings | 1,114,134,000USD | 1,078,747,000USD | 1,109,971,000USD | 1,063,784,000USD | 1,158,169,000USD | 1,069,534,000USD | 1,063,151,000USD | 1,276,971,000USD |
| Accumulated Other Comprehensive Income | -20,721,000USD | -21,055,000USD | -19,026,000USD | -17,867,000USD | -12,629,000USD | -18,375,000USD | -19,554,000USD | -32,460,000USD |
| Intangible Assets | — | 699,925,000USD | 517,916,000USD | 752,526,000USD | 778,999,000USD | 795,209,000USD | 807,103,000USD | 818,246,000USD |
| Total Liab | — | 2,542,213,000USD | 2,488,488,000USD | 2,395,604,000USD | 2,689,257,000USD | 2,532,298,000USD | 2,411,911,000USD | 2,288,693,000USD |
| Other Current Liab | — | 261,504,000USD | 184,657,000USD | 305,885,000USD | 234,505,000USD | 231,825,000USD | 204,939,000USD | 306,640,000USD |
| Common Stock | — | 639,269,000USD | 628,867,000USD | 628,118,000USD | 627,496,000USD | 616,315,000USD | 603,252,000USD | 598,304,000USD |
| Capital Stock | — | 639,269,000USD | 628,867,000USD | 628,118,000USD | 627,496,000USD | 616,315,000USD | 603,252,000USD | 598,304,000USD |
| Good Will | — | 1,780,507,000USD | 1,781,156,000USD | 1,782,095,000USD | 1,782,836,000USD | 1,780,726,000USD | 1,779,682,000USD | 1,782,871,000USD |
| Cash | — | 244,697,000USD | 137,594,000USD | 260,459,000USD | 105,376,000USD | 155,938,000USD | 122,870,000USD | 235,763,000USD |
| Cash And Short Term Investments | — | 244,697,000USD | 137,594,000USD | 260,459,000USD | 105,376,000USD | 155,938,000USD | 122,870,000USD | 235,763,000USD |
| Current Deferred Revenue | — | 37,910,000USD | 46,566,000USD | 53,784,000USD | 70,197,000USD | 79,447,000USD | 78,165,000USD | 83,238,000USD |
| Net Debt | — | 1,383,089,000USD | 1,597,936,000USD | 1,183,708,000USD | 1,675,141,000USD | 1,464,138,000USD | 1,393,048,000USD | 1,041,207,000USD |
| Short Long Term Debt Total | — | 1,627,786,000USD | 1,735,530,000USD | 1,444,167,000USD | 1,780,517,000USD | 1,620,076,000USD | 1,515,918,000USD | 1,276,970,000USD |
| Property Plant Equipment Gross | — | 111,275,000USD | 121,832,000USD | 275,378,000USD | 149,973,000USD | 153,185,000USD | 156,654,000USD | 335,515,000USD |
| Common Stock Shares Outstanding | — | 54,925,000shares | 55,299,000shares | 56,987,000shares | 56,984,000shares | 57,057,000shares | 60,002,000shares | 61,484,000shares |
| Non Current Assets Total | — | 2,730,326,000USD | 2,785,092,000USD | 2,816,715,000USD | 2,857,262,000USD | 2,871,505,000USD | 2,893,382,000USD | 2,930,964,000USD |
| Non Current Liabilities Total | — | 1,860,526,000USD | 1,880,442,000USD | 1,630,440,999USD | 1,983,106,000USD | 1,811,060,999USD | 1,732,986,000USD | 1,481,164,000USD |
| Non Current Liabilities Other | — | 23,534,000USD | 22,043,000USD | 22,637,000USD | 21,582,000USD | 21,444,000USD | 18,331,000USD | 20,195,000USD |
| Non Currrent Assets Other | — | 127,829,000USD | 311,549,000USD | 133,617,000USD | 126,395,000USD | 122,150,000USD | 124,284,000USD | 129,875,000USD |
| Net Working Capital | — | 827,161,000USD | 815,162,000USD | 487,761,000USD | 898,880,000USD | 607,030,000USD | 486,453,000USD | 393,015,000USD |
| Unclassified Current Liabilities | — | -62,971,000USD | -40,552,000USD | -35,359,000USD | -16,953,000USD | -29,378,000USD | — | -13,604,000USD |
| Unclassified Non Current Liabilities | — | 365,176,000USD | 349,194,000USD | 326,210,999USD | 352,542,000USD | 343,870,999USD | 361,438,000USD | 369,015,000USD |
| Unclassified Equity | — | -639,269,000USD | -628,867,000USD | -628,118,000USD | -627,496,000USD | -616,315,000USD | -603,252,000USD | -598,304,000USD |
| Other Assets | — | — | 153,685,000USD | 150,608,000USD | 145,454,000USD | 142,385,000USD | 149,943,000USD | 157,276,000USD |
| Unclassified Non Current Assets | — | — | -138,530,000USD | -133,616,999USD | -126,395,000USD | -122,150,000USD | -124,284,000USD | -129,875,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 4,069,639,000USD | 4,131,508,000USD | 3,985,797,000USD | 3,992,714,000USD | 4,118,965,000USD | 2,024,702,000USD | 1,745,732,000USD | 1,462,000,000USD |
| Intangible Assets | 752,526,000USD | 818,246,000USD | 811,459,000USD | 863,644,000USD | 922,036,000USD | 183,926,000USD | 211,619,000USD | 110,464,000USD |
| Other Current Assets | 90,466,000USD | 79,985,000USD | 89,945,999USD | 86,250,000USD | 82,692,000USD | 55,719,000USD | 51,554,000USD | 43,995,000USD |
| Total Liab | 2,395,604,000USD | 2,288,693,000USD | 2,317,962,000USD | 2,443,343,000USD | 2,638,636,000USD | 782,883,000USD | 497,531,000USD | 375,581,000USD |
| Total Stockholder Equity | 1,674,035,000USD | 1,842,815,000USD | 1,667,835,000USD | 1,549,371,000USD | 1,480,329,000USD | 1,241,819,000USD | 1,247,792,000USD | 1,086,419,000USD |
| Other Current Liab | 305,885,000USD | 306,640,000USD | 243,309,000USD | 294,573,000USD | 221,866,000USD | 159,172,000USD | 119,498,000USD | 11,896,000USD |
| Common Stock | 628,118,000USD | 598,304,000USD | 577,898,000USD | 557,978,000USD | 532,411,000USD | 513,959,000USD | 498,433,000USD | 487,539,000USD |
| Capital Stock | 628,118,000USD | 598,304,000USD | 577,898,000USD | 557,978,000USD | 532,411,000USD | 513,959,000USD | 498,433,000USD | 487,539,000USD |
| Retained Earnings | 1,063,784,000USD | 1,276,971,000USD | 1,117,552,000USD | 1,025,354,000USD | 987,826,000USD | 770,498,000USD | 794,739,000USD | 633,281,000USD |
| Good Will | 1,782,095,000USD | 1,782,871,000USD | 1,779,215,000USD | 1,779,415,000USD | 1,774,406,000USD | 593,129,000USD | 584,469,000USD | 399,882,000USD |
| Other Assets | 150,608,000USD | 157,276,000USD | 105,870,000USD | 132,199,000USD | 101,053,000USD | 71,209,000USD | 60,630,000USD | 65,478,000USD |
| Cash | 260,459,000USD | 235,763,000USD | 122,091,000USD | 136,795,000USD | 156,570,000USD | 88,561,000USD | 116,492,000USD | 349,245,000USD |
| Cash And Equivalents | 222,351,000USD | 183,123,000USD | 65,405,000USD | 40,658,000USD | 135,061,000USD | 71,737,000USD | 105,565,000USD | 349,245,000USD |
| Cash And Short Term Investments | 260,459,000USD | 235,763,000USD | 122,091,000USD | 136,795,000USD | 156,570,000USD | 88,561,000USD | 116,492,000USD | 369,509,000USD |
| Total Current Assets | 1,252,924,000USD | 1,200,544,000USD | 1,055,465,999USD | 1,032,313,000USD | 1,079,494,000USD | 932,558,000USD | 789,425,000USD | 808,632,000USD |
| Total Current Liabilities | 765,163,000USD | 807,529,000USD | 723,014,000USD | 774,447,000USD | 789,433,000USD | 561,168,000USD | 364,238,000USD | 277,449,000USD |
| Current Deferred Revenue | 53,784,000USD | 83,238,000USD | 60,477,000USD | 87,146,000USD | 98,588,000USD | 51,655,000USD | 43,344,000USD | 51,182,000USD |
| Net Debt | 1,183,708,000USD | 1,041,207,000USD | 1,307,121,000USD | 1,369,320,000USD | 1,550,970,000USD | 125,093,000USD | -106,834,000USD | -349,109,000USD |
| Short Term Debt | 91,285,000USD | 87,795,000USD | 136,696,000USD | 127,457,000USD | 156,632,000USD | 91,626,000USD | 9,658,000USD | 99,993,000USD |
| Short Long Term Debt | 52,680,000USD | 40,139,000USD | 86,844,000USD | 63,458,000USD | 80,555,000USD | 10,878,000USD | 9,658,000USD | 136,000USD |
| Short Long Term Debt Total | 1,444,167,000USD | 1,276,970,000USD | 1,429,212,000USD | 1,506,115,000USD | 1,707,540,000USD | 213,654,000USD | 9,889,000USD | 99,993,000USD |
| Long Term Debt | 1,281,593,000USD | 1,091,954,000USD | 1,163,149,000USD | 1,292,483,000USD | 1,429,137,000USD | 18,017,000USD | — | 374,000USD |
| Net Receivables | 901,999,000USD | 884,796,000USD | 843,429,000USD | 809,268,000USD | 840,232,000USD | 788,278,000USD | 621,379,000USD | 395,128,000USD |
| Accounts Payable | 296,888,000USD | 303,321,000USD | 282,081,000USD | 264,553,000USD | 305,565,000USD | 253,338,000USD | 177,786,000USD | 114,378,000USD |
| Property Plant Equipment Net | 131,485,999USD | 172,571,000USD | 202,760,000USD | 185,143,000USD | 241,976,000USD | 243,880,000USD | 99,589,000USD | 77,544,000USD |
| Property Plant Equipment Gross | 275,378,000USD | 335,515,000USD | 202,760,000USD | 185,143,000USD | 241,976,000USD | 243,880,000USD | 99,589,000USD | 77,544,000USD |
| Accumulated Other Comprehensive Income | -17,867,000USD | -32,460,000USD | -27,615,000USD | -33,961,000USD | -39,908,000USD | -42,638,000USD | -45,380,000USD | -36,953,000USD |
| Common Stock Shares Outstanding | 57,921,000shares | 61,484,000shares | 61,450,000shares | 61,969,000shares | 62,365,000shares | 63,322,000shares | 64,819,999shares | 65,932,000shares |
| Non Current Assets Total | 2,816,715,000USD | 2,930,964,000USD | 2,930,331,000USD | 2,960,401,000USD | 3,039,471,000USD | 1,092,144,000USD | 956,307,000USD | 653,368,000USD |
| Non Current Liabilities Total | 1,630,440,999USD | 1,481,164,000USD | 1,594,947,999USD | 1,668,895,999USD | 1,849,203,000USD | 221,715,000USD | 133,293,000USD | 98,132,000USD |
| Non Current Liabilities Other | 22,637,000USD | 20,195,000USD | 13,253,000USD | 22,515,000USD | 56,252,000USD | 112,996,000USD | 20,313,000USD | 38,258,000USD |
| Non Currrent Assets Other | 133,617,000USD | 129,875,000USD | 103,038,000USD | 95,829,000USD | 100,063,000USD | 69,294,000USD | 60,444,000USD | 9,959,000USD |
| Net Working Capital | 487,761,000USD | 393,015,000USD | 332,452,000USD | 257,866,000USD | 290,061,000USD | 371,390,000USD | 425,187,000USD | 531,183,000USD |
| Unclassified Non Current Assets | -133,616,999USD | -129,875,000USD | -72,011,000USD | -95,829,000USD | -100,063,000USD | -69,294,000USD | -60,444,000USD | -9,959,000USD |
| Unclassified Current Liabilities | -35,359,000USD | -13,604,000USD | -86,393,000USD | -62,740,000USD | -73,773,000USD | — | 4,294,000USD | — |
| Unclassified Non Current Liabilities | 326,210,999USD | 369,015,000USD | 70,741,999USD | — | 29,033,000USD | -72,376,000USD | -39,003,000USD | -98,506,000USD |
| Unclassified Equity | -628,118,000USD | -598,304,000USD | -577,898,000USD | -557,978,000USD | -532,411,000USD | -513,959,000USD | -498,433,000USD | -484,987,000USD |
| Deferred Long Term Liab | — | — | 45,372,000USD | 47,732,000USD | 36,486,000USD | 63,391,000USD | 18,921,000USD | 59,874,000USD |
| Other Liab | — | — | 302,432,000USD | 290,238,000USD | 298,295,000USD | 99,687,000USD | 133,062,000USD | 98,132,000USD |
| Short Term Investments | — | — | 56,891,000USD | — | — | — | 0USD | 20,264,000USD |
| Net Tangible Assets | — | — | -922,839,000USD | -1,093,688,000USD | -1,216,113,000USD | 464,764,000USD | 451,704,000USD | 573,521,000USD |
| Unclassified Current Assets | — | — | -56,891,000USD | — | — | — | — | — |
| Inventory | — | — | — | — | -5,413,000USD | -2,075,000USD | -20,805,000USD | 1USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 98,063,000USD | 93,943,000USD | 75,288,000USD | 105,981,000USD | 96,569,000USD | 41,196,000USD | 72,504,000USD | 89,752,000USD |
| Depreciation | 32,625,999USD | 33,189,000USD | 37,173,000USD | 32,617,000USD | 32,436,000USD | 31,490,000USD | 32,849,000USD | 31,072,000USD |
| Stock Based Compensation | 9,899,000USD | 7,019,000USD | 10,858,000USD | 10,749,000USD | 12,623,000USD | 6,952,000USD | 7,744,000USD | 9,481,000USD |
| Other Non Cash Items | 17,549,000USD | -8,249,000USD | 942,000USD | 736,000USD | 1,674,000USD | 38,979,000USD | 635,000USD | 1,697,000USD |
| Change To Account Receivables | 30,710,000USD | -253,375,000USD | 521,445,000USD | -318,415,000USD | -131,428,000USD | -103,454,000USD | -24,034,000USD | 65,857,000USD |
| Change In Working Capital | 1,371,000USD | -398,168,000USD | 535,998,000USD | -327,562,000USD | -97,841,000USD | -200,770,000USD | 82,354,000USD | 62,781,000USD |
| Total Cash From Operating Activities | 189,526,000USD | -244,402,000USD | 649,372,000USD | -182,718,000USD | 42,714,000USD | -79,996,000USD | 163,834,000USD | 199,328,000USD |
| Capital Expenditures | -10,509,000USD | -6,263,000USD | -7,527,000USD | -15,488,000USD | -17,206,000USD | -22,992,000USD | -31,953,000USD | -34,690,000USD |
| Free Cash Flow | 179,017,000USD | -250,665,000USD | 641,845,000USD | -198,206,000USD | 25,508,000USD | -102,988,000USD | 131,881,000USD | 164,638,000USD |
| Total Cashflows From Investing Activities | -10,509,000USD | 6,632,000USD | -3,146,000USD | -15,488,000USD | -19,371,000USD | -22,256,000USD | -31,939,000USD | -34,690,000USD |
| Net Borrowings | -32,500,000USD | 232,500,000USD | -323,673,000USD | 163,673,000USD | 105,625,000USD | 255,736,000USD | -9,377,000USD | — |
| Total Cash From Financing Activities | -113,277,000USD | 156,900,000USD | -490,670,000USD | 146,116,000USD | 8,934,000USD | -8,257,000USD | -45,827,000USD | -135,332,000USD |
| Dividends Paid | -17,821,000USD | -16,338,000USD | -16,845,000USD | -16,904,000USD | -16,901,000USD | -18,060,000USD | -18,054,000USD | -18,239,000USD |
| Sale Purchase Of Stock | -114,440,000USD | -40,562,000USD | -141,039,000USD | -10,000USD | -77,850,000USD | -228,593,000USD | -25,794,000USD | -47,275,000USD |
| Change In Cash | 65,172,000USD | -80,934,000USD | 116,975,000USD | -50,562,000USD | 33,068,000USD | -112,893,000USD | 87,962,000USD | 29,461,000USD |
| Begin Period Cash Flow | 179,525,000USD | 260,459,000USD | 105,376,000USD | 155,938,000USD | 122,870,000USD | 235,763,000USD | 147,801,000USD | 118,340,000USD |
| End Period Cash Flow | 244,697,000USD | 179,525,000USD | 222,351,000USD | 105,376,000USD | 155,938,000USD | 122,870,000USD | 235,763,000USD | 147,801,000USD |
| Other Cashflows From Financing Activities | 51,484,000USD | -18,700,000USD | -9,113,000USD | -643,000USD | -1,940,000USD | -17,340,000USD | 7,398,000USD | -8,537,000USD |
| Unclassified Operating Cash Flow | 30,018,001USD | 27,864,000USD | -10,887,000USD | -5,239,000USD | -2,747,000USD | 2,157,000USD | -32,252,000USD | 4,545,000USD |
| Other Cashflows From Investing Activities | — | 12,895,000USD | 2,952,000USD | -1,429,000USD | -2,165,000USD | 736,000USD | 14,000USD | — |
| Investments | — | — | -3,146,000USD | -15,488,000USD | -19,371,000USD | -22,256,000USD | -31,939,000USD | -34,690,000USD |
| Unclassified Investing Cash Flow | — | — | 4,575,000USD | 16,917,000USD | 19,371,000USD | 22,256,000USD | 31,939,000USD | 34,690,000USD |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | — | -61,281,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 319,034,000USD | 306,914,000USD | 161,792,000USD | 203,828,000USD | 291,200,000USD | 214,509,000USD | 240,495,000USD | 220,816,000USD |
| Depreciation | 133,716,000USD | 125,527,000USD | 149,316,000USD | 132,795,000USD | 90,718,000USD | 100,161,000USD | 85,458,000USD | 62,192,000USD |
| Stock Based Compensation | 41,182,000USD | 35,349,000USD | 29,522,000USD | 30,476,000USD | 28,554,000USD | 23,708,000USD | 20,774,000USD | 20,238,000USD |
| Other Non Cash Items | 42,331,000USD | 4,552,000USD | 3,720,000USD | -8,034,000USD | 9,374,000USD | -1,718,000USD | 189,276,000USD | 113,459,000USD |
| Change To Account Receivables | -31,852,000USD | -50,562,000USD | -23,401,000USD | 14,132,000USD | 38,578,000USD | -141,842,000USD | -60,313,000USD | 34,033,000USD |
| Change In Working Capital | -90,175,000USD | 78,938,000USD | -31,562,000USD | -79,430,000USD | 104,053,000USD | -72,923,000USD | -2,661,000USD | 13,558,000USD |
| Total Cash From Operating Activities | 429,372,000USD | 515,258,000USD | 314,340,000USD | 289,839,000USD | 517,322,000USD | 244,592,000USD | 356,727,000USD | 323,525,000USD |
| Capital Expenditures | -63,213,000USD | -114,190,000USD | -90,695,000USD | -56,145,000USD | -36,565,000USD | -40,707,000USD | -66,846,000USD | -26,520,000USD |
| Free Cash Flow | 366,159,000USD | 401,068,000USD | 223,645,000USD | 233,694,000USD | 480,757,000USD | 203,885,000USD | 289,881,000USD | 297,005,000USD |
| Investments | -60,261,000USD | -129,104,000USD | -80,963,000USD | -54,009,000USD | -1,835,480,000USD | -44,138,000USD | -483,883,000USD | -19,996,000USD |
| Total Cashflows From Investing Activities | -60,261,000USD | -129,104,000USD | -80,963,000USD | -54,009,000USD | -1,835,480,000USD | -44,138,000USD | -483,883,000USD | -46,304,000USD |
| Net Borrowings | 201,361,000USD | -112,036,000USD | -108,675,000USD | -155,658,000USD | 1,470,433,000USD | 18,603,000USD | 9,522,000USD | -137,000USD |
| Total Cash From Financing Activities | -343,877,000USD | -275,646,000USD | -250,798,000USD | -248,271,000USD | 1,385,693,000USD | -230,090,000USD | -110,859,000USD | -91,880,000USD |
| Dividends Paid | -68,710,000USD | -72,901,000USD | -68,073,000USD | -68,716,000USD | -68,838,000USD | -70,155,000USD | -63,887,000USD | -11,692,000USD |
| Sale Purchase Of Stock | -447,482,000USD | -73,069,000USD | -22,255,000USD | -96,119,000USD | -3,363,000USD | -166,959,000USD | -47,446,000USD | -66,919,000USD |
| Change In Cash | 24,696,000USD | 113,672,000USD | -14,704,000USD | -19,775,000USD | 68,009,000USD | -27,931,000USD | -240,067,000USD | 182,993,000USD |
| Begin Period Cash Flow | 235,763,000USD | 122,091,000USD | 136,795,000USD | 156,570,000USD | 88,561,000USD | 116,492,000USD | 356,559,000USD | 166,252,000USD |
| End Period Cash Flow | 260,459,000USD | 235,763,000USD | 122,091,000USD | 136,795,000USD | 156,570,000USD | 88,561,000USD | 116,492,000USD | 349,245,000USD |
| Other Cashflows From Investing Activities | 2,952,000USD | -17,999,000USD | 9,732,000USD | 2,136,000USD | -1,798,915,000USD | -3,431,000USD | 20,449,000USD | 369,000USD |
| Other Cashflows From Financing Activities | -27,388,000USD | -17,640,000USD | 770,249,000USD | 687,222,000USD | -12,539,000USD | -11,579,000USD | -9,048,000USD | -13,132,000USD |
| Unclassified Operating Cash Flow | -16,716,000USD | -36,022,000USD | — | 10,204,000USD | -6,577,000USD | -19,145,000USD | -176,615,000USD | -106,738,000USD |
| Unclassified Investing Cash Flow | 60,261,000USD | 132,189,000USD | 80,963,000USD | 54,009,000USD | 1,835,480,000USD | 44,138,000USD | 46,397,000USD | — |
| Change To Inventory | — | — | 859,000USD | — | -26,904,000USD | -79,930,000USD | -47,580,000USD | 9,874,000USD |
| Change To Liabilities | — | — | 5,606,000USD | -52,064,000USD | 80,556,000USD | 112,904,000USD | 64,068,000USD | -9,258,000USD |
| Unclassified Financing Cash Flow | — | — | -822,044,000USD | -615,000,000USD | — | — | — | — |
| Cash And Cash Equivalents Changes | — | — | — | -12,441,000USD | 67,535,000USD | -29,636,000USD | — | 182,993,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | — | -2,348,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q3 2026Quarterly · 2026-06-30 | Product | Clinical Services | 553,075,000 | USD | Disclosure |
| Q3 2026Quarterly · 2026-06-30 | Product | Employment And Other | 55,852,000 | USD | Disclosure |
| Q3 2026Quarterly · 2026-06-30 | Product | Program Operations | 602,807,000 | USD | Disclosure |
| Q3 2026Quarterly · 2026-06-30 | Product | Technology Solutions | 67,237,000 | USD | Disclosure |
| Q3 2026Quarterly · 2026-06-30 | Segment | Outside The United States | 139,753,000 | USD | Disclosure |
| Q3 2026Quarterly · 2026-06-30 | Segment | U.S.Federal Services | 720,991,000 | USD | Disclosure |
| Q3 2026Quarterly · 2026-06-30 | Segment | USServices | 418,227,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-03-31 | Product | Clinical Services | 530,808,000 | USD | 0001032220-26-000027 |
| Q2 2026Quarterly · 2026-03-31 | Product | Employment And Other | 60,008,000 | USD | 0001032220-26-000027 |
| Q2 2026Quarterly · 2026-03-31 | Product | Program Operations | 644,892,000 | USD | 0001032220-26-000027 |
| Q2 2026Quarterly · 2026-03-31 | Product | Technology Solutions | 70,259,000 | USD | 0001032220-26-000027 |
| Q2 2026Quarterly · 2026-03-31 | Segment | Outside The United States | 137,070,000 | USD | 0001032220-26-000027 |
| Q2 2026Quarterly · 2026-03-31 | Segment | U.S.Federal Services | 753,143,000 | USD | 0001032220-26-000027 |
| Q2 2026Quarterly · 2026-03-31 | Segment | USServices | 415,754,000 | USD | 0001032220-26-000027 |
| Q1 2026Quarterly · 2025-12-31 | Product | Clinical Services | 523,719,000 | USD | 0001032220-26-000014 |
| Q1 2026Quarterly · 2025-12-31 | Product | Employment And Other | 70,165,000 | USD | 0001032220-26-000014 |
| Q1 2026Quarterly · 2025-12-31 | Product | Program Operations | 676,407,000 | USD | 0001032220-26-000014 |
| Q1 2026Quarterly · 2025-12-31 | Product | Technology Solutions | 74,755,000 | USD | 0001032220-26-000014 |
| Q1 2026Quarterly · 2025-12-31 | Segment | Outside The United States | 143,197,000 | USD | 0001032220-26-000014 |
| Q1 2026Quarterly · 2025-12-31 | Segment | U.S.Federal Services | 786,601,000 | USD | 0001032220-26-000014 |
| Q1 2026Quarterly · 2025-12-31 | Segment | USServices | 415,248,000 | USD | 0001032220-26-000014 |
| Q4 2025Quarterly · 2025-09-30 | Segment | Outside The United States | 141,207,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-09-30 | Segment | U.S.Federal Services | 747,935,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-09-30 | Segment | USServices | 429,273,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-09-30 | Product | Advanced Technology Solutions | 324,734,000 | USD | 0001032220-25-000053 |
| FY 2025Yearly · 2025-09-30 | Product | Clinical Services | 2,100,943,000 | USD | 0001032220-25-000053 |
| FY 2025Yearly · 2025-09-30 | Product | Employment And Other | 354,835,000 | USD | 0001032220-25-000053 |
| FY 2025Yearly · 2025-09-30 | Product | Program Operations | 2,650,764,000 | USD | 0001032220-25-000053 |
| FY 2025Yearly · 2025-09-30 | Segment | Outside The United States | 599,894,000 | USD | 0001032220-25-000053 |
| FY 2025Yearly · 2025-09-30 | Segment | U.S.Federal Services | 3,067,691,000 | USD | 0001032220-25-000053 |
| FY 2025Yearly · 2025-09-30 | Segment | USServices | 1,763,691,000 | USD | 0001032220-25-000053 |
| Q3 2025Quarterly · 2025-06-30 | Product | Clinical Services | 560,360,000 | USD | 0001032220-25-000040 |
| Q3 2025Quarterly · 2025-06-30 | Product | Employment And Other | 81,906,000 | USD | 0001032220-25-000040 |
| Q3 2025Quarterly · 2025-06-30 | Product | Program Operations | 626,981,000 | USD | 0001032220-25-000040 |
| Q3 2025Quarterly · 2025-06-30 | Product | Technology Solutions | 79,153,000 | USD | 0001032220-25-000040 |
| Q3 2025Quarterly · 2025-06-30 | Segment | Outside The United States | 147,408,000 | USD | 0001032220-25-000040 |
| Q3 2025Quarterly · 2025-06-30 | Segment | U.S.Federal Services | 761,174,000 | USD | 0001032220-25-000040 |
| Q3 2025Quarterly · 2025-06-30 | Segment | USServices | 439,818,000 | USD | 0001032220-25-000040 |
| Q2 2025Quarterly · 2025-03-31 | Product | Clinical Services | 503,963,000 | USD | 0001032220-26-000027 |
| Q2 2025Quarterly · 2025-03-31 | Product | Employment And Other | 78,989,000 | USD | 0001032220-26-000027 |
| Q2 2025Quarterly · 2025-03-31 | Product | Program Operations | 690,772,000 | USD | 0001032220-26-000027 |
| Q2 2025Quarterly · 2025-03-31 | Product | Technology Solutions | 88,062,000 | USD | 0001032220-26-000027 |
| Q2 2025Quarterly · 2025-03-31 | Segment | Outside The United States | 141,509,000 | USD | 0001032220-26-000027 |
| Q2 2025Quarterly · 2025-03-31 | Segment | U.S.Federal Services | 777,927,000 | USD | 0001032220-26-000027 |
| Q2 2025Quarterly · 2025-03-31 | Segment | USServices | 442,350,000 | USD | 0001032220-26-000027 |
| Q1 2025Quarterly · 2024-12-31 | Product | Clinical Services | 471,526,000 | USD | 0001032220-26-000014 |
| Q1 2025Quarterly · 2024-12-31 | Product | Employment And Other | 113,618,000 | USD | 0001032220-26-000014 |
| Q1 2025Quarterly · 2024-12-31 | Product | Program Operations | 727,967,000 | USD | 0001032220-26-000014 |
| Q1 2025Quarterly · 2024-12-31 | Product | Technology Solutions | 89,564,000 | USD | 0001032220-26-000014 |
| Q1 2025Quarterly · 2024-12-31 | Segment | Outside The United States | 169,770,000 | USD | 0001032220-26-000014 |
| Q1 2025Quarterly · 2024-12-31 | Segment | U.S.Federal Services | 780,655,000 | USD | 0001032220-26-000014 |
| Q1 2025Quarterly · 2024-12-31 | Segment | USServices | 452,250,000 | USD | 0001032220-26-000014 |
| Q4 2024Quarterly · 2024-09-30 | Product | Clinical Services | 490,223,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-09-30 | Product | Employment And Other | 122,900,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-09-30 | Product | Program Operations | 613,460,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-09-30 | Product | Technology Solutions | 89,287,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-09-30 | Segment | Outside The United States | 177,198,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-09-30 | Segment | U.S.Federal Services | 675,117,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-09-30 | Segment | USServices | 463,555,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-09-30 | Product | Advanced Technology Solutions | 375,107,000 | USD | 0001032220-25-000053 |
| FY 2024Yearly · 2024-09-30 | Product | Clinical Services | 1,891,292,000 | USD | 0001032220-25-000053 |
| FY 2024Yearly · 2024-09-30 | Product | Employment And Other | 469,304,000 | USD | 0001032220-25-000053 |
| FY 2024Yearly · 2024-09-30 | Product | Program Operations | 2,570,494,000 | USD | 0001032220-25-000053 |
| FY 2024Yearly · 2024-09-30 | Segment | Outside The United States | 657,140,000 | USD | 0001032220-25-000053 |
| FY 2024Yearly · 2024-09-30 | Segment | U.S.Federal Services | 2,737,244,000 | USD | 0001032220-25-000053 |
| FY 2024Yearly · 2024-09-30 | Segment | USServices | 1,911,813,000 | USD | 0001032220-25-000053 |
| Q3 2024Quarterly · 2024-06-30 | Product | Clinical Services | 506,077,000 | USD | 0001032220-25-000040 |
| Q3 2024Quarterly · 2024-06-30 | Product | Employment And Other | 112,044,000 | USD | 0001032220-25-000040 |
| Q3 2024Quarterly · 2024-06-30 | Product | Program Operations | 604,614,000 | USD | 0001032220-25-000040 |
| Q3 2024Quarterly · 2024-06-30 | Product | Technology Solutions | 92,194,000 | USD | 0001032220-25-000040 |
| FY 2023Yearly · 2023-09-30 | Product | Advanced Technology Solutions | 397,029,000 | USD | 0001032220-25-000053 |
| FY 2023Yearly · 2023-09-30 | Product | Clinical Services | 1,486,040,000 | USD | 0001032220-25-000053 |
| FY 2023Yearly · 2023-09-30 | Product | Employment And Other | 520,981,000 | USD | 0001032220-25-000053 |
| FY 2023Yearly · 2023-09-30 | Product | Program Operations | 2,500,678,000 | USD | 0001032220-25-000053 |
| FY 2023Yearly · 2023-09-30 | Segment | Outside The United States | 689,053,000 | USD | 0001032220-25-000053 |
| FY 2023Yearly · 2023-09-30 | Segment | U.S.Federal Services | 2,403,606,000 | USD | 0001032220-25-000053 |
| FY 2023Yearly · 2023-09-30 | Segment | USServices | 1,812,069,000 | USD | 0001032220-25-000053 |
| FY 2022Yearly · 2022-09-30 | Product | Clinical Services | 1,176,081,000 | USD | 0001032220-24-000094 |
| FY 2022Yearly · 2022-09-30 | Product | Employment And Other | 551,755,000 | USD | 0001032220-24-000094 |
| FY 2022Yearly · 2022-09-30 | Product | Program Operations | 2,502,620,000 | USD | 0001032220-24-000094 |
| FY 2022Yearly · 2022-09-30 | Product | Technology Solutions | 400,562,000 | USD | 0001032220-24-000094 |
| FY 2022Yearly · 2022-09-30 | Segment | Outside The United States | 763,662,000 | USD | 0001032220-24-000094 |
| FY 2022Yearly · 2022-09-30 | Segment | U.S.Federal Services | 2,259,744,000 | USD | 0001032220-24-000094 |
| FY 2022Yearly · 2022-09-30 | Segment | USServices | 1,607,612,000 | USD | 0001032220-24-000094 |
| Q4 2022Quarterly · 2022-09-30 | Geography | Australia | 30,000,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-09-30 | Geography | Restof World | 37,063,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-09-30 | Geography | United Kingdom | 107,106,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-09-30 | Geography | United States | 1,002,862,000 | USD | Legacy provider |
| FY 2022Yearly · 2022-09-30 | Geography | Australia | 173,078,000 | USD | 0001032220-22-000074 |
| FY 2022Yearly · 2022-09-30 | Geography | Restof World | 179,999,000 | USD | 0001032220-22-000074 |
| FY 2022Yearly · 2022-09-30 | Geography | United Kingdom | 410,587,000 | USD | 0001032220-22-000074 |
| FY 2022Yearly · 2022-09-30 | Geography | United States | 3,867,354,000 | USD | 0001032220-22-000074 |
| Q3 2022Quarterly · 2022-06-30 | Geography | Australia | 43,594,000 | USD | 0001032220-22-000046 |
| Q3 2022Quarterly · 2022-06-30 | Geography | Restof World | 47,576,000 | USD | 0001032220-22-000046 |
| Q3 2022Quarterly · 2022-06-30 | Geography | United Kingdom | 109,776,000 | USD | 0001032220-22-000046 |
| Q3 2022Quarterly · 2022-06-30 | Geography | United States | 924,839,000 | USD | 0001032220-22-000046 |
| Q2 2022Quarterly · 2022-03-31 | Geography | Australia | 46,670,000 | USD | 0001032220-22-000022 |
| Q2 2022Quarterly · 2022-03-31 | Geography | Restof World | 51,393,000 | USD | 0001032220-22-000022 |
| Q2 2022Quarterly · 2022-03-31 | Geography | United Kingdom | 107,898,000 | USD | 0001032220-22-000022 |
| Q2 2022Quarterly · 2022-03-31 | Geography | United States | 971,365,000 | USD | 0001032220-22-000022 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.